Xi'an International Medical Investment Balance Sheet Health
Financial Health criteria checks 1/6
Xi'an International Medical Investment has a total shareholder equity of CN¥3.5B and total debt of CN¥4.5B, which brings its debt-to-equity ratio to 129.5%. Its total assets and total liabilities are CN¥10.6B and CN¥7.1B respectively.
Key information
129.5%
Debt to equity ratio
CN¥4.51b
Debt
Interest coverage ratio | n/a |
Cash | CN¥499.97m |
Equity | CN¥3.48b |
Total liabilities | CN¥7.08b |
Total assets | CN¥10.55b |
Recent financial health updates
Xi'an International Medical Investment (SZSE:000516) Is Making Moderate Use Of Debt
Nov 21Xi'an International Medical Investment (SZSE:000516) Is Carrying A Fair Bit Of Debt
Jul 16Does Xi'an International Medical Investment (SZSE:000516) Have A Healthy Balance Sheet?
Mar 25Recent updates
Xi'an International Medical Investment (SZSE:000516) Is Making Moderate Use Of Debt
Nov 21After Leaping 27% Xi'an International Medical Investment Company Limited (SZSE:000516) Shares Are Not Flying Under The Radar
Oct 01Xi'an International Medical Investment (SZSE:000516) Is Carrying A Fair Bit Of Debt
Jul 16Investors Still Waiting For A Pull Back In Xi'an International Medical Investment Company Limited (SZSE:000516)
Jun 20Does Xi'an International Medical Investment (SZSE:000516) Have A Healthy Balance Sheet?
Mar 25Xi'an International Medical Investment Company Limited (SZSE:000516) Not Lagging Industry On Growth Or Pricing
Feb 28Financial Position Analysis
Short Term Liabilities: 000516's short term assets (CN¥1.5B) do not cover its short term liabilities (CN¥3.9B).
Long Term Liabilities: 000516's short term assets (CN¥1.5B) do not cover its long term liabilities (CN¥3.1B).
Debt to Equity History and Analysis
Debt Level: 000516's net debt to equity ratio (115.1%) is considered high.
Reducing Debt: 000516's debt to equity ratio has increased from 59.3% to 129.5% over the past 5 years.
Debt Coverage: 000516's debt is well covered by operating cash flow (22.7%).
Interest Coverage: Insufficient data to determine if 000516's interest payments on its debt are well covered by EBIT.